1
|
Mondal B. Crystal structure of di-ethyl-ammonium dioxido{ Z)- N-[(pyri-din-2-yl)car-bon-yl-azan-idyl]pyri-dine-2-car-box-imid-ato}vana-date(1-) monohydrate. Acta Crystallogr E Crystallogr Commun 2024; 80:277-280. [PMID: 38456060 PMCID: PMC10915662 DOI: 10.1107/s2056989024001166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2023] [Accepted: 02/03/2024] [Indexed: 03/09/2024]
Abstract
The title compound, (C4H12N)[V(C12H8N4O2)O2]·H2O, was synthesized via aerial oxidation on refluxing picolinohydrazide with ethyl picolinate followed by addition of VIVO(acac)2 and di-ethyl-amine in methanol. It crystallizes in the triclinic crystal system in space group P . In the complex anion, the dioxidovanadium(V) moiety exhibits a distorted square-pyramidal geometry. In the crystal, extensive hydrogen bonding links the water mol-ecule to two complex anions and one di-ethyl-ammonium ion. One of the CH2 groups in the di-ethyl-amine is disordered over two sets of sites in a 0.7:0.3 ratio.
Collapse
Affiliation(s)
- Bipul Mondal
- Department of Chemistry, Ramakrishna Mission Vivekananda Centenary College, Rahara, Kolkata-700118, West Bengal, India
| |
Collapse
|
2
|
Kaur M, Kaushal R. Spectroscopic investigations, ab-initio DFT calculations, molecular docking and in-vitro assay studies of novel oxovanadium(V)chalcone complexes as potential antidiabetic agents. J Mol Struct 2023. [DOI: 10.1016/j.molstruc.2022.133994] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
3
|
A combined experimental and theoretical study to demonstrate the importance of V2O4 synthon in the crystal packing of an oxo-bridged dinuclear vanadium(V) complex with V2O4 core. Inorganica Chim Acta 2022. [DOI: 10.1016/j.ica.2022.121279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
4
|
Recent Updates on Development of Protein-Tyrosine Phosphatase 1B Inhibitors for Treatment of Diabetes, Obesity and Related Disorders. Bioorg Chem 2022; 121:105626. [DOI: 10.1016/j.bioorg.2022.105626] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2021] [Revised: 12/19/2021] [Accepted: 01/13/2022] [Indexed: 01/30/2023]
|
5
|
Miao F, Zhang M, Zhou Y. Syntheses and structures of two new inorganic-organic hybrid nickel vanadates [Ni(H2biim)3]V2O6 and [Ni(H2biim)3][(VO2)(SO4)] (H2biim=2,2′-biimidazole). J Mol Struct 2022. [DOI: 10.1016/j.molstruc.2021.131286] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
6
|
The dual inhibition against the activity and expression of tyrosine phosphatase PRL-3 from a rhodanine derivative. Bioorg Med Chem Lett 2021; 41:127981. [PMID: 33766767 DOI: 10.1016/j.bmcl.2021.127981] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2020] [Revised: 02/12/2021] [Accepted: 03/14/2021] [Indexed: 11/22/2022]
Abstract
Increasing evidences demonstrated that PRL-3 was associated with metastatic potential in a variety of cancers including CRC, gastric cancer, ovarian cancer and so on. PRL-3 knock down inhibited the development of metastasis by reducing the size of primary tumors and inhibiting the invasion and growth of cancer cells. Therefore, PRL-3 is a promising diagnostic marker and therapeutic target in tumors. So far, only several PRL-3 inhibitors have been reported. In this study, six rhodanine derivatives were synthesized and characterized. The compounds were evaluated against tyrosine phosphatase PRL-3. Among these compounds, 5-(5-chloro-2-(trifluoromethyl)benzylidene)-2-thioxothiazolidin-4-one (4) could effectively inhibit PRL-3 with IC50 value of 15.22 μM. Fluorescent assays suggested compound 4 tightly bound to tyrosine phosphatase PRL-3 with the molar ratio of 1:1, and the binding constant of 1.74 × 106 M-1. Compound 4 entered into SW-480 cells, selectively inhibited the expression of PRL-3 and increased the phosphorylation of PRL-3 substrates, and decreased the survival rate of SW-480 cells with IC50 of 6.64 μM and induced apoptosis. The results revealed that compound 4 is a dual functional inhibitor against the activity and expression of PRL-3 and a promising anti-cancer candidate targeting PRL-3.
Collapse
|
7
|
Turtoi M, Anghelache M, Patrascu AA, Maxim C, Manduteanu I, Calin M, Popescu DL. Synthesis, Characterization, and In Vitro Insulin-Mimetic Activity Evaluation of Valine Schiff Base Coordination Compounds of Oxidovanadium(V). Biomedicines 2021; 9:562. [PMID: 34067862 PMCID: PMC8156053 DOI: 10.3390/biomedicines9050562] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2021] [Revised: 05/11/2021] [Accepted: 05/14/2021] [Indexed: 11/17/2022] Open
Abstract
Type 2 diabetes became an alarming global health issue since the existing drugs do not prevent its progression. Herein, we aimed to synthesize and characterize a family of oxidovanadium(V) complexes with Schiff base ligands derived from L-/D-valine (val) and salicylaldehyde (sal) or o-vanillin (van) as insulin-mimetic agents and to assess their potential anti-diabetic properties. Two new oxidovanadium(V) complexes, [{VVO(R-salval)(H2O)}(μ2-O){VVO(R-salval)}] and [{VVO(R-vanval)(CH3OH)}2(μ2-O)], and their S-enantiomers were synthesized and characterized. The compounds exhibit optical activity as shown by crystallographic and spectroscopic data. The stability, the capacity to bind bovine serum albumin (BSA), the cytotoxicity against human hepatoma cell line, as well as the potential anti-diabetic activity of the four compounds are investigated. The synthesized compounds are stable for up to three hours in physiological conditions and exhibit a high capacity of binding to BSA. Furthermore, the synthesized compounds display cytocompatibility at biologically relevant concentrations, exert anti-diabetic potential and insulin-mimetic activities by inhibiting the α-amylase and protein tyrosine phosphatase activity, and a long-term increase of insulin receptor phosphorylation compared to the insulin hormone. Thus, the in vitro anti-diabetic potential and insulin-mimetic properties of the newly synthesized oxidovanadium(V) compounds, correlated with their cytocompatibility, make them promising candidates for further investigation as anti-diabetic drugs.
Collapse
Affiliation(s)
- Mihaela Turtoi
- Medical and Pharmaceutical Bionanotechnologies Laboratory, Institute of Cellular Biology and Pathology Nicolae Simionescu of the Romanian Academy, 8 B.P. Hasdeu, 050568-Bucharest, Romania; (M.A.); (I.M.)
| | - Maria Anghelache
- Medical and Pharmaceutical Bionanotechnologies Laboratory, Institute of Cellular Biology and Pathology Nicolae Simionescu of the Romanian Academy, 8 B.P. Hasdeu, 050568-Bucharest, Romania; (M.A.); (I.M.)
| | - Andrei A. Patrascu
- Department of Inorganic Chemistry, Faculty of Chemistry, University of Bucharest, 23 Dumbrava Roşie, 020464-Bucharest, Romania; (A.A.P.); (C.M.)
| | - Catalin Maxim
- Department of Inorganic Chemistry, Faculty of Chemistry, University of Bucharest, 23 Dumbrava Roşie, 020464-Bucharest, Romania; (A.A.P.); (C.M.)
| | - Ileana Manduteanu
- Medical and Pharmaceutical Bionanotechnologies Laboratory, Institute of Cellular Biology and Pathology Nicolae Simionescu of the Romanian Academy, 8 B.P. Hasdeu, 050568-Bucharest, Romania; (M.A.); (I.M.)
| | - Manuela Calin
- Medical and Pharmaceutical Bionanotechnologies Laboratory, Institute of Cellular Biology and Pathology Nicolae Simionescu of the Romanian Academy, 8 B.P. Hasdeu, 050568-Bucharest, Romania; (M.A.); (I.M.)
| | - Delia-Laura Popescu
- Department of Inorganic Chemistry, Faculty of Chemistry, University of Bucharest, 23 Dumbrava Roşie, 020464-Bucharest, Romania; (A.A.P.); (C.M.)
| |
Collapse
|
8
|
Mirdarvatan V, Bahramian B, Khalaji AD, Poupon M, Dusek M, Mazandarani R. A new vanadium complex having [OVV(µ-O)2VVO] core with anti-coplanar configuration: Synthesis, crystal structure, DFT calculation, antibacterial and a homogeneous catalyst for epoxidation of alkenes. Polyhedron 2021. [DOI: 10.1016/j.poly.2020.114939] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|
9
|
Synthesis and Characterization of Serendipitous Dioxovanadates and Their DNA/BSA Interaction Studies and In Vitro Cytotoxic activity. J Inorg Organomet Polym Mater 2020. [DOI: 10.1007/s10904-020-01815-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
|
10
|
El‐Afify ME, Elsayed SA, Shalaby TI, Toson EA, El‐Hendawy AM. Synthesis, characterization, DNA binding/cleavage, cytotoxic, apoptotic, and antibacterial activities of V(IV), Mo(VI), and Ru(II) complexes containing a bioactive ONS‐donor chelating agent. Appl Organomet Chem 2020. [DOI: 10.1002/aoc.6082] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Affiliation(s)
- Marwa E. El‐Afify
- Chemistry Department, Faculty of Science Damietta University New Damietta 34517 Egypt
| | - Shadia A. Elsayed
- Chemistry Department, Faculty of Science Damietta University New Damietta 34517 Egypt
| | - Thanaa I. Shalaby
- Medical Biophysics Department, Medical Research Institute Alexandria University Alexandria 21561 Egypt
| | - Elshahat A. Toson
- Chemistry Department, Faculty of Science Damietta University New Damietta 34517 Egypt
| | - Ahmed M. El‐Hendawy
- Chemistry Department, Faculty of Science Damietta University New Damietta 34517 Egypt
| |
Collapse
|
11
|
Lei S, Zhang D, Qi Y, Chowdhury SR, Sun R, Wang J, Du Y, Fu L, Jiang F. Synthesis and biological evaluation of geniposide derivatives as potent and selective PTPlB inhibitors. Eur J Med Chem 2020; 205:112508. [PMID: 32738350 DOI: 10.1016/j.ejmech.2020.112508] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2020] [Revised: 05/20/2020] [Accepted: 05/23/2020] [Indexed: 02/08/2023]
Abstract
Herein a series of Geniposide derivatives were designed, synthesized and evaluated as protein tyrosine phosphatase 1B (PTPlB) inhibitors. Most of these compounds exhibited potent in vitro PTP1B inhibitory activities, the representative 7a and 17f were found to be the most potent inhibitors against the enzyme with IC50 values of 0.35 and 0.41 μM, respectively. More importantly, they showcased 4 to10-fold selectivity over SHP2 and 3-fold over TCPTP. Further biological activity studies revealed that compounds 7a, 17b and 17f could effectively enhance insulin-stimulated glucose uptake with no significant cytotoxicity. Subsequent molecular docking and structural activity relationship analyses demonstrated that the glucose scaffold, benzylated glycosyl groups, and arylethenesulfonic acid ester significantly impact on the activity and selectivity.
Collapse
Affiliation(s)
- Shuwen Lei
- School of Pharmacy, Shanghai Jiao Tong University, No. 800 Dongchuan Rd. Minhang District, Shanghai, 200240, PR China
| | - Dongdong Zhang
- School of Pharmacy, Shanghai Jiao Tong University, No. 800 Dongchuan Rd. Minhang District, Shanghai, 200240, PR China
| | - Yunyue Qi
- School of Pharmacy, Shanghai Jiao Tong University, No. 800 Dongchuan Rd. Minhang District, Shanghai, 200240, PR China
| | - Sharmin Reza Chowdhury
- School of Pharmacy, Shanghai Jiao Tong University, No. 800 Dongchuan Rd. Minhang District, Shanghai, 200240, PR China
| | - Ran Sun
- School of Pharmacy, Shanghai Jiao Tong University, No. 800 Dongchuan Rd. Minhang District, Shanghai, 200240, PR China
| | - Juntao Wang
- School of Pharmacy, Shanghai Jiao Tong University, No. 800 Dongchuan Rd. Minhang District, Shanghai, 200240, PR China
| | - Yi Du
- Xinhua Hospital Affiliated to Shanghai Jiao Tong University, School of Medicine, No. 1665 Kongjiang Rd., Yangpu District, Shanghai, 200092, PR China
| | - Lei Fu
- School of Pharmacy, Shanghai Jiao Tong University, No. 800 Dongchuan Rd. Minhang District, Shanghai, 200240, PR China.
| | - Faqin Jiang
- School of Pharmacy, Shanghai Jiao Tong University, No. 800 Dongchuan Rd. Minhang District, Shanghai, 200240, PR China.
| |
Collapse
|
12
|
Manimohan M, Pugalmani S, Ravichandran K, Sithique MA. Synthesis and characterisation of novel Cu(ii)-anchored biopolymer complexes as reusable materials for the photocatalytic degradation of methylene blue. RSC Adv 2020; 10:18259-18279. [PMID: 35692624 PMCID: PMC9122621 DOI: 10.1039/d0ra01724h] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2020] [Accepted: 04/06/2020] [Indexed: 11/21/2022] Open
Abstract
Biopolymer-incorporated Cu(ii) complexes are proven to be excellent photocatalysts for the degradation of organic dyes (methylene blue) under UV-visible light.
Collapse
Affiliation(s)
| | | | - K. Ravichandran
- Department of Analytical Chemistry
- University of Madras
- Guindy Campus
- Chennai
- India
| | | |
Collapse
|
13
|
Yuan C, Wang W, Wang J, Li X, Wu YB, Li S, Lu L, Zhu M, Xing S, Fu X. Potent and selective PTP1B inhibition by a platinum(ii) complex: possible implications for a new antitumor strategy. Chem Commun (Camb) 2019; 56:102-105. [PMID: 31793564 DOI: 10.1039/c9cc06972k] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Showing anti-proliferation activity against MCF7 cells better than cisplatin, a platinum(ii) complex, [PtL(DMSO)Cl], was found to potently and selectively inhibit protein tyrosine phosphatase 1B (PTP1B), a putative target for anticancer agents, suggesting a new possible anticancer strategy based on platinum drugs.
Collapse
Affiliation(s)
- Caixia Yuan
- Institute of Molecular Science, Key Laboratory of Chemical Biology and Molecular Engineering of the Education Ministry, Shanxi University, Taiyuan, Shanxi 030006, P. R. China.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Lin L, Lu L, Du R, Yuan C, Zhu M, Fu X, Xing S. A Ce(iii) complex potently inhibits the activity and expression of tyrosine phosphatase SHP-2. Dalton Trans 2019; 48:17673-17682. [PMID: 31763642 DOI: 10.1039/c9dt03200b] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Four new Ce(iii) complexes 1-4 with tridentate NNO-donor Schiff base ligands have been designed and successfully synthesized. These complexes were characterized by elemental analysis, IR, and ESI-MS, with formulas of [Ce(HL1)2(NO3)3]·2CH3OH (1), [Ce(L2)2(NO3)]·3H2O (2), [Ce(HL3)(L3)(NO3)Br]·H2O (3) and [Ce(L4)2(NO3)]·3H2O (4), in which ligands HL1-HL4 are respectively N'-[(1E)-pyridin-2-ylmethylidene]pyrazine-2-carbohydrazide (HL1), 2-(1-(salicyloylhydrazono)ethyl)pyrazine (HL2), N'-[(1E)-pyridin-2-ylmethylidene]pyridine-2-carbohydrazide (HL3) and 2-(1-(salicyloylhydrazono)ethyl) pyridine (HL4). X-ray single crystal diffraction analysis indicates that complex 1 crystallizes in the monoclinic system with the space group C2/c and the structure of complex 1 consists of a monomeric Ce(iii) species with a Ce(iii) moiety bonded to two tridentate Schiff base ligands, three nitrates and solvents. These complexes effectively inhibit the enzyme activities of PTPs (SHP-1, SHP-2, TCPTP and PTP1B), among which complex 3 shows the most potent inhibition of SHP-2 with the lowest IC50 value of 0.61 μM and displays obvious selectivity towards SHP-2. Its inhibition potency against SHP-2 was approximately 17, 4, and 5 fold higher than that against SHP-1, TCPTP and PTP1B, respectively. Further study discloses that complex 3 inhibits SHP-2 in a competitive manner. Fluorescence measurements indicate that complex 3 tightly binds to SHP-2 with a molar ratio of 1 : 1 and a binding constant of 5.45 × 105 M-1. Western blot experiments show that complex 3 promotes the phosphorylation of the SHP-2 substrate by the combination of the inhibition of the activity and expression of SHP-2. Moreover, complex 3 decreases the survival rate of A549 cells to 35.12% at 100 μM and induces apoptosis with an apoptosis rate of 12.06% at 50 μM. All these results suggest that complex 3 is a potential bi-functional inhibitor of the activity and expression of tyrosine phosphatase SHP-2.
Collapse
Affiliation(s)
- Lixia Lin
- Institute of Molecular Science, Key Laboratory of Chemical Biology and Molecular Engineering of the Education Ministry, Shanxi University, Taiyuan, Shanxi 030006, People's Republic of China.
| | | | | | | | | | | | | |
Collapse
|
15
|
Discovery of 2-ethoxy-4-(methoxymethyl)benzamide derivatives as potent and selective PTP1B inhibitors. Bioorg Chem 2019; 92:103273. [DOI: 10.1016/j.bioorg.2019.103273] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2019] [Revised: 08/14/2019] [Accepted: 09/09/2019] [Indexed: 11/24/2022]
|
16
|
Lu LP, Suo FZ, Feng YL, Song LL, Li Y, Li YJ, Wang KT. Synthesis and biological evaluation of vanadium complexes as novel anti-tumor agents. Eur J Med Chem 2019; 176:1-10. [PMID: 31082759 DOI: 10.1016/j.ejmech.2019.04.073] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2018] [Revised: 04/17/2019] [Accepted: 04/29/2019] [Indexed: 02/06/2023]
Abstract
A class of vanadium complexes were prepared and investigated for their antiproliferative effects by MTT assay. The structure-activity relationship was extensively studied through the ligand variation. The results showed that the synthetic vanadium complexes demonstrated moderate to good antiproliferative activities against the four cancer cell lines including MGC803, EC109, MCF7 and HepG2, respectively. Of note was that most of the complexes showed preferential growth inhibitory activity to some degree toward gastric cancer line MGC803. Among them, complex 19 exhibited the most and broad-spectrum proliferative inhibition against the tested cell lines. In addition, mechanism studies illustrated that complex 19 could prevent the colony formation, migration and EMT process, as well as induce apoptosis of MGC803 cells. Furthermore, Western blot experiments revealed that the expression of apoptosis-related proteins changed, including up-regulation of Bax, PARP and caspase-3/9, as well as down-regulation of Bcl-2.
Collapse
Affiliation(s)
- Ling-Pan Lu
- School of Pharmaceutical Sciences, Zhengzhou University of Industrial Technology, Zhengzhou, 451199, PR China
| | - Feng-Zhi Suo
- School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, PR China
| | - Ya-Li Feng
- School of Pharmaceutical Sciences, Zhengzhou University of Industrial Technology, Zhengzhou, 451199, PR China
| | - Li-Li Song
- School of Pharmaceutical Sciences, Zhengzhou University of Industrial Technology, Zhengzhou, 451199, PR China
| | - Ying Li
- Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450001, PR China
| | - Yang-Jie Li
- School of Pharmaceutical Sciences, Zhengzhou University of Industrial Technology, Zhengzhou, 451199, PR China
| | - Kai-Ti Wang
- School of Materials Science and Engineering, Chongqing University of Technology, Chongqing, 400054, PR China.
| |
Collapse
|
17
|
Identification of novel imidazole flavonoids as potent and selective inhibitors of protein tyrosine phosphatase. Bioorg Chem 2019; 88:102900. [PMID: 30991192 DOI: 10.1016/j.bioorg.2019.03.074] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2018] [Revised: 03/18/2019] [Accepted: 03/30/2019] [Indexed: 01/12/2023]
Abstract
A series of imidazole flavonoids as new type of protein tyrosine phosphatase inhibitors were synthesized and characterized. Most of them gave potent protein phosphatase 1B (PTP1B) inhibitory activities. Especially, compound 11a could effectively inhibit PTP1B with an IC50 value of 0.63 μM accompanied with high selectivity ratio (9.5-fold) over T-cell protein tyrosine phosphatase (TCPTP). This compound is cell permeable with relatively low cytotoxicity. The high binding affinity and selectivity was disclosed by molecular modeling and dynamics studies. The structural features essential for activity were confirmed by quantum chemical studies.
Collapse
|
18
|
Exploration of Zinc(II) Complexes as Potent Inhibitors Against Protein Tyrosine Phosphatase 1B. Chem Res Chin Univ 2019. [DOI: 10.1007/s40242-019-8265-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
|
19
|
Treviño S, Díaz A, Sánchez-Lara E, Sanchez-Gaytan BL, Perez-Aguilar JM, González-Vergara E. Vanadium in Biological Action: Chemical, Pharmacological Aspects, and Metabolic Implications in Diabetes Mellitus. Biol Trace Elem Res 2019; 188:68-98. [PMID: 30350272 PMCID: PMC6373340 DOI: 10.1007/s12011-018-1540-6] [Citation(s) in RCA: 167] [Impact Index Per Article: 33.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/06/2018] [Accepted: 10/01/2018] [Indexed: 12/12/2022]
Abstract
Vanadium compounds have been primarily investigated as potential therapeutic agents for the treatment of various major health issues, including cancer, atherosclerosis, and diabetes. The translation of vanadium-based compounds into clinical trials and ultimately into disease treatments remains hampered by the absence of a basic pharmacological and metabolic comprehension of such compounds. In this review, we examine the development of vanadium-containing compounds in biological systems regarding the role of the physiological environment, dosage, intracellular interactions, metabolic transformations, modulation of signaling pathways, toxicology, and transport and tissue distribution as well as therapeutic implications. From our point of view, the toxicological and pharmacological aspects in animal models and humans are not understood completely, and thus, we introduced them in a physiological environment and dosage context. Different transport proteins in blood plasma and mechanistic transport determinants are discussed. Furthermore, an overview of different vanadium species and the role of physiological factors (i.e., pH, redox conditions, concentration, and so on) are considered. Mechanistic specifications about different signaling pathways are discussed, particularly the phosphatases and kinases that are modulated dynamically by vanadium compounds because until now, the focus only has been on protein tyrosine phosphatase 1B as a vanadium target. Particular emphasis is laid on the therapeutic ability of vanadium-based compounds and their role for the treatment of diabetes mellitus, specifically on that of vanadate- and polioxovanadate-containing compounds. We aim at shedding light on the prevailing gaps between primary scientific data and information from animal models and human studies.
Collapse
Affiliation(s)
- Samuel Treviño
- Facultad de Ciencias Químicas, Benemérita Universidad Autónoma de Puebla, 14 Sur y Av. San Claudio, Col. San Manuel, C.P. 72570 Puebla, PUE Mexico
| | - Alfonso Díaz
- Facultad de Ciencias Químicas, Benemérita Universidad Autónoma de Puebla, 14 Sur y Av. San Claudio, Col. San Manuel, C.P. 72570 Puebla, PUE Mexico
| | - Eduardo Sánchez-Lara
- Centro de Química, ICUAP, Benemérita Universidad Autónoma de Puebla, 14 Sur y Av. San Claudio, Col. San Manuel, C.P. 72570 Puebla, PUE Mexico
| | - Brenda L. Sanchez-Gaytan
- Centro de Química, ICUAP, Benemérita Universidad Autónoma de Puebla, 14 Sur y Av. San Claudio, Col. San Manuel, C.P. 72570 Puebla, PUE Mexico
| | - Jose Manuel Perez-Aguilar
- Facultad de Ciencias Químicas, Benemérita Universidad Autónoma de Puebla, 14 Sur y Av. San Claudio, Col. San Manuel, C.P. 72570 Puebla, PUE Mexico
| | - Enrique González-Vergara
- Centro de Química, ICUAP, Benemérita Universidad Autónoma de Puebla, 14 Sur y Av. San Claudio, Col. San Manuel, C.P. 72570 Puebla, PUE Mexico
| |
Collapse
|
20
|
Xie F, Yang F, Liang Y, Li L, Xia Y, Jiang F, Liu W, Qi Y, Chowdhury SR, Xie D, Fu L. Investigation of stereoisomeric bisarylethenesulfonic acid esters for discovering potent and selective PTP1B inhibitors. Eur J Med Chem 2019; 164:408-422. [DOI: 10.1016/j.ejmech.2018.12.032] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2018] [Revised: 12/11/2018] [Accepted: 12/14/2018] [Indexed: 01/03/2023]
|
21
|
Zhang L, Ge Y, Song HM, Wang QM, Zhou CH. Design, synthesis of novel azolyl flavonoids and their protein tyrosine Phosphatase-1B inhibitory activities. Bioorg Chem 2018; 80:195-203. [DOI: 10.1016/j.bioorg.2018.06.008] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2018] [Revised: 05/30/2018] [Accepted: 06/03/2018] [Indexed: 12/15/2022]
|
22
|
Kerru N, Singh-Pillay A, Awolade P, Singh P. Current anti-diabetic agents and their molecular targets: A review. Eur J Med Chem 2018; 152:436-488. [PMID: 29751237 DOI: 10.1016/j.ejmech.2018.04.061] [Citation(s) in RCA: 185] [Impact Index Per Article: 30.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2017] [Revised: 04/17/2018] [Accepted: 04/30/2018] [Indexed: 12/22/2022]
Abstract
Diabetes mellitus is a medical condition characterized by the body's loss of control over blood sugar. The frequency of diagnosed cases and consequential increases in medical costs makes it a rapidly growing chronic disease that threatens human health worldwide. In addition, its unnerving statistical projections are perilous to both the economy of the nation and man's life expectancy. Type-I and type-II diabetes are the two clinical forms of diabetes mellitus. Type-II diabetes mellitus (T2DM) is illustrated by the abnormality of glucose homeostasis in the body, resulting in hyperglycemia. Although significant research attention has been devoted to the development of diabetes regimens, which demonstrates success in lowering blood glucose levels, their efficacies are unsustainable due to undesirable side effects such as weight gain and hypoglycemia. Over the years, heterocyclic scaffolds have been the basis of anti-diabetic chemotherapies; hence, in this review we consolidate the use of bioactive scaffolds, which have been evaluated for their biological response as inhibitors against their respective anti-diabetic molecular targets over the past five years (2012-2017). Our investigation reveals a diverse target set which includes; protein tyrosine phosphatase 1 B (PTP1B), dipeptidly peptidase-4 (DPP-4), free fatty acid receptors 1 (FFAR1), G protein-coupled receptors (GPCR), peroxisome proliferator activated receptor-γ (PPARγ), sodium glucose co-transporter-2 (SGLT2), α-glucosidase, aldose reductase, glycogen phosphorylase (GP), fructose-1,6-bisphosphatase (FBPase), glucagon receptor (GCGr) and phosphoenolpyruvate carboxykinase (PEPCK). This review offers a medium on which future drug design and development toward diabetes management may be modelled (i.e. optimization via structural derivatization), as many of the drug candidates highlighted show promise as an effective anti-diabetic chemotherapy.
Collapse
Affiliation(s)
- Nagaraju Kerru
- School of Chemistry and Physics, University of KwaZulu-Natal, P/Bag X54001, Westville, Durban, South Africa
| | - Ashona Singh-Pillay
- School of Chemistry and Physics, University of KwaZulu-Natal, P/Bag X54001, Westville, Durban, South Africa.
| | - Paul Awolade
- School of Chemistry and Physics, University of KwaZulu-Natal, P/Bag X54001, Westville, Durban, South Africa
| | - Parvesh Singh
- School of Chemistry and Physics, University of KwaZulu-Natal, P/Bag X54001, Westville, Durban, South Africa.
| |
Collapse
|
23
|
Siqueira JD, Menegatti AC, Terenzi H, Pereira MB, Roman D, Rosso EF, Piquini PC, Iglesias BA, Back DF. Synthesis, characterization and phosphatase inhibitory activity of dioxidovanadium(V) complexes with Schiff base ligands derived from pyridoxal and resorcinol. Polyhedron 2017. [DOI: 10.1016/j.poly.2017.04.004] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
|